 |
| Ralph Weissleder |
Imagine sending a tiny probe into
the bloodstream with the power to home in on cancers just
as they are forming. Imagine also that this microscopic
trouble-shooter could not only relay information about what
kind of therapeutic approach might best kill the cells,
but could later revisit the danger spots and tell whether
the treatment was working.
FULL
STORY
|
